Companies / Citius Oncology, Inc.
Citius Oncology, Inc.
Nasdaq: CTORTENKUCIK 1851484CRANFORD, NJ
Financials
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jul 28, 2025 | Mayersohn Joel David Director | Other Other (per filing) | Common Stock | $0 | +21K | 21,228 0.02% of shares | low |
| Sep 19, 2025 | Holubiak Myron Z Executive | Grant Grant or award | Common Stock | $0 | +100K | 100,000 0.11% of shares | low |
| Sep 19, 2025 | Holubiak Myron Z Executive | Grant Grant or award | Common Stock | $0 | +850K | 850,000 0.91% of shares | low |
| Sep 19, 2025 | Dutia Suren G Director | Grant Grant or award | Common Stock | $0 | +300K | 300,000 0.32% of shares | low |
| Sep 19, 2025 | Smith Robert Joseph Director | Grant Grant or award | Common Stock | $0 | +300K | 300,000 0.32% of shares | low |
| Sep 19, 2025 | Mazur Leonard L CEO | Grant Grant or award | Common Stock | $0 | +1.7M | 1,700,000 1.83% of shares | low |
| Sep 19, 2025 | Webb Carol Director | Grant Grant or award | Common Stock | $0 | +300K | 300,000 0.32% of shares | low |
| Sep 19, 2025 | McGrath Dennis M Director | Grant Grant or award | Common Stock | $0 | +300K | 300,000 0.32% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CTOR | common | 17331Y109 |